Julien Dodet
Director Ejecutivo en Orano Med LLC .
Perfil
Julien Dodet is associated with three companies, namely Orano Med LLC, Orano Med SAS, and Orano Cycle SA. He is currently serving as the President & Chief Executive Officer of Orano Med LLC and President, CEO & Member-Governors Board of Orano Med SAS.
Additionally, he is also serving as the Director of Orano Cycle SA since 2019.
Cargos activos de Julien Dodet
Empresas | Cargo | Inicio |
---|---|---|
Orano Med LLC
Orano Med LLC Medical SpecialtiesHealth Technology Orano Med LLC develops targeted cancer therapies using lead-212 (212Pb). The company is based in Bethesda, MD. The company is ultimately controlled by the Government of France. The CEO of the company is Julien Dodet. | Director Ejecutivo | - |
Orano Cycle SA
Orano Cycle SA Other Metals/MineralsNon-Energy Minerals Orano Cycle SA provides nuclear fuel cycle services. It specializes in uranium mining conversion and enrichment. The company is headquartered in Chatillon, France. | Director/Miembro de la Junta | 14/12/2019 |
Orano Med SAS
Orano Med SAS BiotechnologyHealth Technology Orano Med SAS is a French biotechnology company that utilizes nuclear technology to develop new therapies for cancer patients with resistant forms of cancer. The company is based in Châtillon, France, and the CEO of the company is Julien Dodet. The company specializes in targeted alpha therapy treatments, which combines biological molecules to target cancer cells with the properties of lead-212 (212pb) to destroy them while limiting the impact on surrounding healthy cells. Orano Med has formed collaborations with prestigious institutions and biopharmaceutical companies to develop several treatments using 212pb combined with various targeting agents. The company has 212pb manufacturing facilities, laboratories, and R&D centers in France and the United States and is currently investing to expand its GMP-manufacturing capacities for 212pb radiolabeled pharmaceuticals. Orano Med is ultimately controlled by the Government of France. | Director Ejecutivo | - |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
Empresas privadas | 3 |
---|---|
Orano Med LLC
Orano Med LLC Medical SpecialtiesHealth Technology Orano Med LLC develops targeted cancer therapies using lead-212 (212Pb). The company is based in Bethesda, MD. The company is ultimately controlled by the Government of France. The CEO of the company is Julien Dodet. | Health Technology |
Orano Cycle SA
Orano Cycle SA Other Metals/MineralsNon-Energy Minerals Orano Cycle SA provides nuclear fuel cycle services. It specializes in uranium mining conversion and enrichment. The company is headquartered in Chatillon, France. | Non-Energy Minerals |
Orano Med SAS
Orano Med SAS BiotechnologyHealth Technology Orano Med SAS is a French biotechnology company that utilizes nuclear technology to develop new therapies for cancer patients with resistant forms of cancer. The company is based in Châtillon, France, and the CEO of the company is Julien Dodet. The company specializes in targeted alpha therapy treatments, which combines biological molecules to target cancer cells with the properties of lead-212 (212pb) to destroy them while limiting the impact on surrounding healthy cells. Orano Med has formed collaborations with prestigious institutions and biopharmaceutical companies to develop several treatments using 212pb combined with various targeting agents. The company has 212pb manufacturing facilities, laboratories, and R&D centers in France and the United States and is currently investing to expand its GMP-manufacturing capacities for 212pb radiolabeled pharmaceuticals. Orano Med is ultimately controlled by the Government of France. | Health Technology |
- Bolsa de valores
- Insiders
- Julien Dodet